Defining Predictors of RT Response to Vedolizumab in IBD
Clinical trial NCT03142321 · COMPLETED
Trial details
- NCT number
- NCT03142321
- Sponsor
- Washington University School of Medicine
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2018-06-08
- Primary completion
- 2024-05-22
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.